{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T09:45:39Z","timestamp":1764841539231},"reference-count":33,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2006,6,1]],"date-time":"2006-06-01T00:00:00Z","timestamp":1149120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,10]],"date-time":"2019-12-10T00:00:00Z","timestamp":1575936000000},"content-version":"vor","delay-in-days":4940,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2006,6]]},"DOI":"10.1093\/annonc\/mdl039","type":"journal-article","created":{"date-parts":[[2006,3,9]],"date-time":"2006-03-09T02:04:29Z","timestamp":1141869869000},"page":"920-927","source":"Crossref","is-referenced-by-count":59,"title":["Patients with grade 3 follicular lymphoma have prolonged relapse-free survival following anthracycline-based chemotherapy: the Nebraska Lymphoma Study Group Experience"],"prefix":"10.1016","volume":"17","author":[{"given":"A.K.","family":"Ganti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.D.","family":"Weisenburger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.M.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.P.","family":"Hans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.G.","family":"Bociek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.J.","family":"Bierman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Vose","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.O.","family":"Armitage","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdl039_bb0010","series-title":"Cancer: Principles and Practice of Oncology","first-page":"2256","article-title":"Non-Hodgkin's lymphomas","author":"Armitage","year":"2001"},{"key":"10.1093\/annonc\/mdl039_bb0015","first-page":"213","article-title":"Follicular lymphoma: expanding therapeutic options","volume":"19","author":"Ganti","year":"2005","journal-title":"Oncology"},{"key":"10.1093\/annonc\/mdl039_bb0020","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1002\/hon.2900010209","article-title":"Criteria for the cytologic classification of follicular lymphomas: a proposed alternative method","volume":"1","author":"Mann","year":"1983","journal-title":"Hematol Oncol"},{"key":"10.1093\/annonc\/mdl039_bb0025","series-title":"World Health Organization Classification of Tumours. Pathology and Genetics of Tumours of Hematopoietic and Lymphoid Tissues","first-page":"162","article-title":"Follicular lymphoma","author":"Nathwani","year":"2001"},{"key":"10.1093\/annonc\/mdl039_bb0030","first-page":"3835","article-title":"World Health Organization classification of neoplastic diseases haematopoietic and lymphoid tissues: report of the Clinical Advisory Committee Meeting, Airlie House, Virginia","volume":"17","author":"Harris","year":"1999","journal-title":"November 1997. J Clin Oncol"},{"key":"10.1093\/annonc\/mdl039_bb0035","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1200\/JCO.1984.2.7.811","article-title":"Follicular large cell lymphoma: analysis and prognostic factors in 62 patients","volume":"2","author":"Kantarjian","year":"1984","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl039_bb0040","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1023\/A:1008330311886","article-title":"Follicular large cell lymphoma long-term follow-up of 62 patients treated between 1973 and 1981","volume":"11","author":"Rodriguez","year":"2000","journal-title":"Ann Oncol"},{"key":"10.1093\/annonc\/mdl039_bb0045","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1200\/JCO.1993.11.2.218","article-title":"Clinical features and prognosis of follicular large-cell lymphoma: a report from the Nebraska Lymphoma Study Group","volume":"11","author":"Anderson","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl039_bb0050","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1182\/blood.V93.7.2202","article-title":"Follicular large cell lymphoma: an aggressive lymphoma that often presents with favorable prognostic features","volume":"93","author":"Rodriguez","year":"1999","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdl039_bb0055","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1200\/JCO.1994.12.7.1349","article-title":"Follicular large-cell lymphoma: intermediate or low grade?","volume":"12","author":"Bartlett","year":"1994","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl039_bb0060","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1002\/1097-0142(19820301)49:5<840::AID-CNCR2820490503>3.0.CO;2-9","article-title":"Nodular histiocytic lymphoma: factors influencing prognosis and implications for aggressive therapy","volume":"49","author":"Glick","year":"1982","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdl039_bb0065","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1182\/blood.V56.1.98.98","article-title":"Nodular histiocytic lymphoma: an aggressive nodular lymphoma with potential for prolonged disease-free survival","volume":"56","author":"Osborne","year":"1980","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdl039_bb0070","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1200\/JCO.1997.15.4.1654","article-title":"Follicular large-cell lymphoma treated with intensive chemotherapy: an analysis of 89 cases included in the LNH87 trial and comparison with the outcome of diffuse large B-cell lymphoma. Groupe d'Etude des Lymphomes de l'Adulte","volume":"15","author":"Wendum","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl039_bb0075","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1200\/JCO.1993.11.2.202","article-title":"What's the deal with follicular lymphomas?","volume":"11","author":"Longo","year":"1993","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl039_bb0080","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0889-8588(05)70468-8","article-title":"Follicular lymphomas: do histologic subtypes predict outcome?","volume":"11","author":"Miller","year":"1997","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1093\/annonc\/mdl039_bb0085","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1182\/blood-2002-07-2298","article-title":"A significant diffuse component predicts for inferior survival in grade 3 follicular lymphoma, but cytologic subtypes do not predict survival","volume":"101","author":"Hans","year":"2003","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdl039_bb0090","first-page":"987","article-title":"A predictive model for aggressive non-Hodgkin's lymphoma","volume":"329","year":"1993","journal-title":"The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med"},{"key":"10.1093\/annonc\/mdl039_bb0095","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1182\/blood-2003-12-4434","article-title":"Follicular lymphoma international prognostic index","volume":"104","author":"Solal-Celigny","year":"2004","journal-title":"Blood"},{"issue":"Suppl","key":"10.1093\/annonc\/mdl039_bb0100","first-page":"4","article-title":"Comparison of front-line chemotherapy for aggressive non-Hodgkin's lymphoma using the CAP-BOP regimens. The Nebraska Lymphoma Study Group","volume":"31","author":"Vose","year":"1994","journal-title":"Semin Hematol"},{"key":"10.1093\/annonc\/mdl039_bb0105","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/0959-8049(95)00076-3","volume":"31A","author":"Bezwoda","year":"1995","journal-title":"Eur J Cancer"},{"key":"10.1093\/annonc\/mdl039_bb0110","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1056\/NEJM199304083281404","article-title":"Comparison of a standard regimen (CHOP) with three intensive chemotherapy regimens for advanced non-Hodgkin's lymphoma","volume":"328","author":"Fisher","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdl039_bb0115","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/01621459.1958.10501452","article-title":"Non-parametric estimation from incomplete observations","volume":"53","author":"Kaplan","year":"1958","journal-title":"J Am Stat Assoc"},{"key":"10.1093\/annonc\/mdl039_bb0120","first-page":"3909","volume":"89","author":"Blood","year":"1997","journal-title":"The Non-Hodgkin's Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin's lymphoma"},{"key":"10.1093\/annonc\/mdl039_bb0125","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1200\/JCO.1985.3.1.25","article-title":"Morphological subclassification of follicular lymphoma: variability of diagnoses among hematopathologists, a collaborative study between the Repository Center and Pathology Panel for Lymphoma Clinical Studies","volume":"3","author":"Metter","year":"1985","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdl039_bb0130","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1002\/1097-0142(197304)31:4<806::AID-CNCR2820310408>3.0.CO;2-1","article-title":"Non-Hodgkin's lymphomas. IV. Clinicopathologic correlation in 405 cases","volume":"31","author":"Jones","year":"1973","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdl039_bb0135","first-page":"2112","volume":"49","author":"Cancer","year":"1982","journal-title":"National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage"},{"key":"10.1093\/annonc\/mdl039_bb0140","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/1097-0142(19860115)57:2<288::AID-CNCR2820570217>3.0.CO;2-5","article-title":"Large non-cleaved follicular center cell lymphoma: clinical features in 53 patients","volume":"57","author":"Stewart","year":"1986","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdl039_bb0145","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/1097-0142(19870415)59:8<1470::AID-CNCR2820590813>3.0.CO;2-K","article-title":"Clinical and pathologic features of follicular large cell (nodular histiocytic) lymphoma","volume":"59","author":"Horning","year":"1987","journal-title":"Cancer"},{"key":"10.1093\/annonc\/mdl039_bb0150","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/sj.bjc.6601006","article-title":"Outcome of follicular lymphoma grade 3: is anthracycline necessary as front-line therapy?","volume":"89","author":"Chau","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1093\/annonc\/mdl039_bb0155","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1080\/1042819031000123564","article-title":"Intergruppo Italiano Linfomi. The role of anthracyclines in combination chemotherapy for the treatment of follicular lymphoma: retrospective study of the Intergruppo Italiano Linfomi on 761 cases","volume":"44","author":"Rigacci","year":"2003","journal-title":"Leuk Lymphoma"},{"key":"10.1093\/annonc\/mdl039_bb0160","first-page":"142a","article-title":"Grading of follicular lymphoma: diagnostic accuracy, reproducibility, and clinical relevance","volume":"11","author":"Weisenburger","year":"1998","journal-title":"Mod Pathol"},{"key":"10.1093\/annonc\/mdl039_bb0165","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1182\/blood-2005-01-0016","volume":"106","author":"Hiddemann","year":"2005","journal-title":"Blood"},{"key":"10.1093\/annonc\/mdl039_bb0170","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1093\/annonc\/mdf198","article-title":"Age-related differences among patients with follicular lymphoma and the importance of prognostic scoring systems: analysis from a population-based non-Hodgkin's lymphoma registry","volume":"13","author":"Maartense","year":"2002","journal-title":"Ann Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419435667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419435667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/17\/6\/920\/495024\/mdl039.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,23]],"date-time":"2021-06-23T07:40:24Z","timestamp":1624434024000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419435667"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,6]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2006,6]]}},"alternative-id":["S0923753419435667"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdl039","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2006,6]]}}}